Algo version: 0.98b
Ambrx Biopharma Inc is listed at the NYSE Exchange
Ambrx Biopharma Inc [AMAM]
NYSE Sector: Healthcare Industry:Biotechnology

Is Ambrx Biopharma Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Ambrx Biopharma Inc 10 years ago, but if you had invested on Friday 18th of June 2021 when the price was $17.05, you would have made a profit of $10.95 per share or 64.22%

Yes, the average daily trading liquidity for Ambrx Biopharma Inc is $1.94 million. You should therefore be able to get in and out of your positions relatively fast.

Ambrx Biopharma Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Ambrx Biopharma Inc to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.